These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics. Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591 [TBL] [Abstract][Full Text] [Related]
3. [Furazolidone and cimetidine in patients with active duodenal ulcer and Helicobacter pylori in the gastric antrum]. Coelho LG; Passos Mdo C; Queiroz DM; Barbosa AJ; Mendes EN; Rocha GA; de Oliveira CA; Lima Júnior GF; Fernandes ML; Castro Lde P Arq Gastroenterol; 1991; 28(1):9-15. PubMed ID: 1843090 [TBL] [Abstract][Full Text] [Related]
4. Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. Maconi G; Bordi C; Cesana B; Pilato FP; Damilano I; Franceschi M; Annibale B Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):501-6. PubMed ID: 9513822 [TBL] [Abstract][Full Text] [Related]
5. [Changes in the natural history of peptic ulcer after Helicobacter pylori eradication. Randomized, double-blind, placebo controlled trial. Follow-up of 44 months]. Piñero R; Ramon Poleo J; Urrestarazo M; Serrano N; Olavarría R G E N; 1995; 49(1):50-4. PubMed ID: 8566673 [TBL] [Abstract][Full Text] [Related]
6. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study. Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413 [TBL] [Abstract][Full Text] [Related]
7. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
8. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial. Fallone CA; Loo V; Joseph L; Barkun J; Kostyk R; Barkun AN Clin Invest Med; 1999 Oct; 22(5):185-94. PubMed ID: 10579057 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study. Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222 [TBL] [Abstract][Full Text] [Related]
10. Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era. Ad Hoc Committee on FDA-Related Matters. Neil GA Am J Gastroenterol; 1997 Mar; 92(3):387-93. PubMed ID: 9068456 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group. Massarrat S; Ihm P; Koch HK Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428 [TBL] [Abstract][Full Text] [Related]
12. Continuous maintenance with low-dose lansoprazole versus Helicobacter pylori eradication in the prevention of duodenal ulcer recurrence. Parente F; Bargiggia S; Bollani S; Colombo E; Bianchi Porro G Hepatogastroenterology; 1998; 45(22):990-3. PubMed ID: 9755995 [TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up. Bytzer P; Teglbjaerg PS; Am J Gastroenterol; 2001 May; 96(5):1409-16. PubMed ID: 11374675 [TBL] [Abstract][Full Text] [Related]
14. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting. Rosengren H; Polson RJ Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626 [TBL] [Abstract][Full Text] [Related]
15. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence]. Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208 [TBL] [Abstract][Full Text] [Related]
16. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study]. Multiple Center Study Group In Beijing Area, China Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1161-5. PubMed ID: 15387976 [TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Lazzaroni M; Perego M; Bargiggia S; Maconi G; Fiocca R; Solcia E; Franceschi M; Cesana B; Bianchi Porro G Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):220-7. PubMed ID: 9646213 [TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Ciociola AA; McSorley DJ; Turner K; Sykes D; Palmer JB Am J Gastroenterol; 1999 Jul; 94(7):1834-40. PubMed ID: 10406244 [TBL] [Abstract][Full Text] [Related]